TG Therapeutics Inc (TGTX)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 41,929 | -505 | 101,845 | 48,355 | 20,633 | -18,944 | -168,691 | -162,958 | -192,838 | -233,723 | -283,888 | -322,439 | -344,769 | -338,604 | -339,198 | -312,551 | -273,594 | -224,773 | -199,912 | -184,611 |
| Revenue (ttm) | US$ in thousands | 329,004 | 262,359 | 340,582 | 280,254 | 222,343 | 180,883 | 18,875 | 6,331 | 2,784 | 5,025 | 6,961 | 7,912 | 6,689 | 4,406 | 2,414 | 907 | 152 | 152 | 152 | 152 |
| Operating profit margin | 12.74% | -0.19% | 29.90% | 17.25% | 9.28% | -10.47% | -893.73% | -2,573.97% | -6,926.65% | -4,651.20% | -4,078.26% | -4,075.32% | -5,154.27% | -7,685.07% | -14,051.28% | -34,459.87% | -179,996.05% | -147,876.97% | -131,521.05% | -121,454.61% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $41,929K ÷ $329,004K
= 12.74%
TG Therapeutics Inc's operating profit margin has shown a significant improvement over the period analyzed. Starting from negative percentages in the range of hundreds of thousands in early 2020, the company gradually reduced its operating losses and turned them into positive figures by the end of 2023. This transformation indicates enhanced operational efficiency and profitability. The operating profit margin continued to rise in 2024, reaching 12.74% by the end of December. Overall, the trend suggests that the company has successfully managed its operating expenses and increased revenue generation, resulting in a healthier margin.
Peer comparison
Dec 31, 2024